This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-esp: Archive
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
MPWRPositive Net Change ORCLPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PFEPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Cadence (CDNS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cadence (CDNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CDNSPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BMYNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
JNJPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SOLVPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RPRXPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Fidelity National (FIS) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Fidelity National (FIS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FISNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will ConocoPhillips (COP) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
ConocoPhillips (COP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
COPNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Ametek (AME) Could Beat Earnings Estimates Again
by Zacks Equity Research
Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AMEPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate